Ms. Maritza Juarbe, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1331 Tongue Cove Dr, Lusby, MD 20657 Phone: 443-404-5195 |
Nicole Anna Smith, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 225 Town Square Dr Ste 3, Lusby, MD 20657 Phone: 410-231-0488 Fax: 410-449-6171 |
Mrs. Dawn M Edwards, LGSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 225 Town Square Dr, Suite 3, Lusby, MD 20657 Phone: 410-231-0488 Fax: 410-449-6171 |
Maura Vilkoski Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 225 Town Square Dr Ste 3, Lusby, MD 20657 Phone: 410-231-0488 Fax: 410-449-6171 |
Ms. Velea Renee Kelley, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 225 Town Square Dr, Box 1550, Lusby, MD 20657 Phone: 410-231-0488 Fax: 410-449-6171 |
News Archive
Understanding of fibromuscular dysplasia (FMD), a rare blood vessel disease, is making the jump from the laboratory to the clinic with new findings about a genetic variant.
An Inserm research team in Toulouse, led by Dr Stein Silva (Inserm Unit 825 "Brain imaging and neurological handicaps"), working with the "Modelling tissue and nociceptive stress" Host Team (MATN IFR 150), were interested in studying the illusions described by many patients under regional anaesthetic.
At the request of the U.S. Food and Drug Administration, U.S. Marshals on Tuesday seized a wide range of human and animal food products stored under insanitary conditions at Mid-States Closeouts, a distribution warehouse in Ellsworth, Wis. The products were seized under a warrant issued by the U.S. District Court for the Western District of Wisconsin.
Researchers found evidence that 'robopets' can provide comfort and pleasure and reduce agitation and loneliness.
AstraZeneca and Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LYNPARZA (olaparib) for use in patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have been previously treated with chemotherapy in the neoadjuvant, adjuvant or metastatic setting.
› Verified 3 days ago